Head-to-head · WeighScore
Alan Meds vs MedLeanRx
By GLP-1 ScorecardUpdated
Score comparison
MedLeanRx has the higher recorded score — 73.9/100 to 65.7/100.
MedLeanRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MedLeanRx is a physician-guided telehealth weight-loss clinic serving Texas only, based in Spring, TX.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Alan Meds | MedLeanRx |
|---|---|---|
| WeighScore | 65.7/100 | 73.9/100 |
| Grade | C | C |
| Site position | #238 | #74 |
| Semaglutide | $158/mo equivalent (2-month upfront promotion, compounded) | $149/mo (starting dose, promotional rate, compounded) |
| Tirzepatide | $325/mo equivalent (6-month upfront plan, compounded) | $269/mo (starting dose, compounded) |
| Coverage | Eligibility depends on state, prescription and pharmacy | 1 state |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #238 · C
FDAWarning letter issued to Alan Health Technologies Inc. dba Alan in February 2026. See the FDA warning-letter database.
Strengths
- Advertised compounded injection pricing stays the same across doses
- Online care with a choice of injection and sublingual preparations
- Outside-pharmacy choice described; separate charges may apply
- Public catalog lists branded Wegovy and Zepbound options
What to consider
- Lowest compounded price labels require upfront multi-month payment
- First renewal may process early; cancel before the actual processing deadline
- Unused subscription periods are not refundable under the ordinary terms
- Rejection-refund promise differs from broader medical-consent wording
Site position #74 · C
Strengths
- Compounded semaglutide $149/mo in both weekly injection and daily oral tablet form
- Brand pathway for Wegovy, Zepbound, and Foundayo (orforglipron) at a $99/mo fee plus medication cost
- Intro bundle: 2 months of compounded tirzepatide (2 mg weekly) for $325 — about $163/mo
- LegitScript seal displayed; named supervising physician (Dr. Johnson Uzor, MD)
- Free shipping, no hidden fees, and cancel-anytime plans per homepage trust chips
What to consider
- Texas only — not available in the other 49 states
- Compounded tirzepatide is $269/mo at standard pricing, above the ~$249 market median
- Strict no-refund policy: 'All sales are final' per Terms & Conditions
- Pharmacy partner not publicly named — a transparency gap for a compounding service
- Legal entity name and founding details not published on the site
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.